Suggested Dosing
Fibromyalgia
10 g tablets PO plus 100 mL liquid extract qDay
Increased Chemo/Radiation tolerability in patients with brain tumors
Up to 20 g PO qDay plus 150 mL liquid extract
Suggested Uses
Cancer prevention, hyperlipidemia, drug/toxin detoxification, fibromyalgia, reducing radiation treatment side effects, stimulating the immune system, improving response to flu vaccine, preventing colds, protecting the body against toxic metals, & slowing aging process
Efficacy
Animal studies have demonstrated antitumor, hypolipidemic & detoxifying abilities; convincing human studies lacking
Fibromyalgia: Preliminary clinical research shows subjective improvements in general symptoms. More studies are needed
Glioma: Early research suggests increased tolerance to chemo/radiation, possibly through improved immune system. More studies are needed
Interactions
Interaction Checker
No Results
Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor
Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (0)
Minor (12)
- antithrombin alfa
chlorella decreases effects of antithrombin alfa by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- antithrombin III
chlorella decreases effects of antithrombin III by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- argatroban
chlorella decreases effects of argatroban by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- bemiparin
chlorella decreases effects of bemiparin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- bivalirudin
chlorella decreases effects of bivalirudin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- dabigatran
chlorella decreases effects of dabigatran by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- dalteparin
chlorella decreases effects of dalteparin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- enoxaparin
chlorella decreases effects of enoxaparin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- fondaparinux
chlorella decreases effects of fondaparinux by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- heparin
chlorella decreases effects of heparin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- phenindione
chlorella decreases effects of phenindione by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
- protamine
chlorella decreases effects of protamine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical, due to vitamin K content.
Adverse Effects
Allergic reactions, photosensitivity
Warnings
Contraindications
Hypersensitivity
Pregnancy, lactation
Cautions
Some supplements may be rich in vitamin K
Allergic diathesis
Pregnancy & Lactation
Pregnancy Category: avoid
Lactation: avoid
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Metabolism: no studies but lipids & carbohydrates should follow normal metabolic processes
Excretion: N/A
Mechanism of Action
Antitumor activity may be mediated by immunopotentiation
Mechanism of hypolipidemic & detoxifying effects unknown
